The maker of the birth control patch Ortho Evra issued two warnings back in 2006, one on February 16 and the other on September 25, that women who use the patch face three times the risk of developing blood clots than those that take the pill. These warnings come after the FDA issued a warning on November 10, 2005 that patch users were being exposed to a higher dose of hormones, and therefore are at a higher risk of blood clots and other serious side effects.

Patch-maker Ortho McNeil had claimed that the patch exposed users to the same risks as the most common birth control pills found on the market. But in response to the November FDA warning, Ortho McNeil added a strongly worded warning to the patch label saying women using the patch would be exposed to almost 60 percent more estrogen than those using typical birth-control pills.

NuvaRing, manufactured by Organon, is a prescription birth control device that releases estrogen and progesterone into the bloodstream. The problem is that these high levels of hormones can cause blood-clotting issues; such as embolisms or deep vein thrombosis (DVT), serious injuries that could cause severe health consequences. These types of health risks are very similar to the risks associated with the Ortho Evra Patch, and were known and documented for several years.

Significant claims against the manufacturer of the Ortho Evra Patch are settling and ongoing. We are also investigating consumer claims that NuvaRing birth control is causing the same permanent and serious injuries as the Ortho Evra Patch.

If you or a loved one has used the Ortho Evra Patch or the NuvaRing and then experienced any serious injuries, call us today for free, private consultation.

CLICK HERE to contact us today, or send an email to Info@HelpingTheInjured.com